Skip to main content
Figure 4 | Journal for ImmunoTherapy of Cancer

Figure 4

From: Immunoglobulin-like transcript 2 (ILT2) is a biomarker of therapeutic response to oncolytic immunotherapy with vaccinia viruses

Figure 4

ILT2 expression by T cell populations in melanoma patients before and after rV-B7.1 treatment. (A- D) Frequency of peripheral blood cells expressing (A) FoxP3 among CD4+ T cells and ILT2 among (B) CD4+ T cells, (C) CD8+ T cells, and (D) CD4+FoxP3+ T cells was evaluated by flow cytometry in metastatic melanoma patients (nā€‰=ā€‰4) before (pre) and after (post) intra-tumoral rV-B7.1 treatment.

Back to article page